title: Different levels of leptin regulate different target enzymes involved in progesterone synthesis.
abstract: OBJECTIVE
  To study the effects of different doses of leptin on the expression of proteins involved in P synthesis, such as steroidogenic acute regulatory protein (StAR), cytochrome P450 side chain cleavage (P450scc), and 3β-hydroxysteroid dehydrogenase (3βHSD).
  
  
  METHODS
  Experimental studies.
  
  
  METHODS
  Research laboratory.
  
  
  METHODS
  Immature rats primed with gonadotropins to induce ovulation.
  
  
  METHODS
  In vivo studies: rats received either an acute or daily treatment with leptin. In vitro studies: ovarian explants were cultured in the absence or presence of leptin (0.3-500 ng/mL).
  
  
  METHODS
  The expression of both messenger RNA and protein of StAR, P450scc, and 3βHSD were measured by reverse transcription-polymerase chain reaction (PCR) and Western blot, respectively.
  
  
  RESULTS
  The acute treatment with leptin, which inhibits the ovulatory process, caused a significant reduction in the ovarian expression of P450scc without changes in StAR or 3βHSD. In contrast, the daily treatment, which induces the ovulatory process, showed an increased expression of the ovarian 3βHSD protein, without differences in the other proteins measured. We also found that leptin increased the protein of both P450scc and 3βHSD at physiological levels and inhibited both messenger RNA and protein of 3βHSD at higher concentrations.
  
  
  CONCLUSIONS
  The results indicate that 1) leptin is able to regulate the expression of the 3βHSD protein in a dose-dependent manner; and 2) leptin seems to exert its dual effects on P synthesis on different targets in a dose-dependent manner.
authors: Centro de Estudios Farmacológicos y Botánicos (CEFYBO-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
authors: María Guillermina
authors: MG
authors: Bilbao
authors: María Paula
authors: MP
authors: Di Yorio
authors: Alicia Graciela
authors: AG
authors: Faletti
mesh_terms: D015096:3-Hydroxysteroid Dehydrogenases / Q000235:genetics* / Q000378:metabolism; D000367:Age Factors; D000818:Animals; D002786:Cholesterol Side-Chain Cleavage Enzyme / Q000235:genetics* / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005260:Female; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects / Q000502:physiology; D006062:Gonadotropins / Q000494:pharmacology; D020738:Leptin / Q000494:pharmacology / Q000502:physiology*; D010060:Ovulation / Q000187:drug effects / Q000502:physiology; D010062:Ovulation Induction / Q000379:methods; D010750:Phosphoproteins / Q000235:genetics* / Q000378:metabolism; D011374:Progesterone / Q000096:biosynthesis*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D000098682:Steroidogenic Acute Regulatory Protein
chemical_list: D006062:Gonadotropins; D020738:Leptin; D010750:Phosphoproteins; D012333:RNA, Messenger; D000098682:Steroidogenic Acute Regulatory Protein; D011374:Progesterone; D015096:3-Hydroxysteroid Dehydrogenases; D002786:Cholesterol Side-Chain Cleavage Enzyme